Kotak Mahindra ties with Metropolis to offer COVIPROTECT Test at 30% off

Kotak Debit and Credit cardholders can avail the COVIPROTECT Spike antibody blood test at a 30% discount at all Metropolis diagnostics centers in Mumbai and over 90 cities across India.

Jun 22, 2021 12:06 IST India Infoline News Service

To help assess one’s antibody levels, Kotak Mahindra Bank Ltd (KMBL) has announced an exclusive offer for its customers in a tie-up with Metropolis Healthcare Limited. Kotak Debit and Credit cardholders can avail the COVIPROTECT Spike antibody blood test at a 30% discount at all Metropolis diagnostics centres in Mumbai and over 90 cities across India.

The Quantitative SARS CoV2 Antibody Test Against Spike Protein helps measure the level of antibodies that a person has either after having been vaccinated or post COVID-19 infection. COVID antibodies protect one against future infection.

Thus, this simple test can help people measure their immunity levels against COVID-19.

The test which costs Rs 1200/- will be available at a reduced price of Rs 850/- for all Kotak customers.

KMBL Debit and Credit card customers can book the test online on Metropolis’ website or via its call centre. The test can be done at home or at any of Metropolis’ diagnostics centres. For the home test, there is an extra charge for home collection of the sample.

Puneet Kapoor, President - Products, Alternate Channels and Customer Experience Delivery, Kotak Mahindra Bank said, “As India slowly starts to unlock and we begin to resume our everyday lives, it is extremely important that we take the necessary precautions to keep ourselves and our families safe.

Metropolis’ COVIPROTECT test is a simple blood test that determines if our bodies have developed sufficient antibodies to protect us against the virus. Through our tie-up with Metropolis, we are pleased to offer this essential test at a 30% discount to our Kotak customers.

Dr. Nilesh Shah, Group President, Metropolis Healthcare said, “Metropolis has been at the forefront of COVID testing from day one of the pandemic. Post recovery from COVID-19 and vaccination, citizens did not have any access to a test to accurately determine the level of immunity that was developed.

With ‘COVIPROTECT’, we strive to provide citizens across the country with accurate insights and understanding of their immunity. As the country slowly unlocks, it is important for all of us to continue being careful in the battle against COVID-19 and its variants. With the help of Kotak Mahindra Bank Ltd., we shall continue contributing towards this battle and the overall healthcare system of our country."

“It goes without saying that even if one’s antibody levels are adequate, we must continue to observe all safety measures such as using masks, washing hands regularly & maintaining social distancing just like before,” added Dr. Shah.

At around 12:10 PM, Kotak Mahindra Bank was trading at Rs1,777 apiece up by Rs4.35 or 0.25% on the BSE.

Related Story

Open Free Demat Account (Rs699)